Can Platify 25mg Tablet be given with other medication?

Yes, Platify 25mg Tablet can be given in combination with other medicine based on doctor's assessment about your disease and its stage.Consult the doctor about drug interaction.

What if I miss the dose of Platify 25mg Tablet?

Take the Platify 25mg Tablet as soon as you remember it unless its near the time of next dose. Avoid over dosage of medicine as it can cause harm to the body.

How long is the treatment duration with Platify 25mg Tablet medication?

Platify 25mg Tablet medication course usually varies, depending on the multiple factors such as patient's overall health, disease etc.

Does Platify 25mg Tablet affect the kidney and liver of the body?

Yes, Platify 25mg Tablet negatively effect the kidney as well as liver of the body to a great extent if not monitored timely.

Buy Platify 25mg Tablet Online: Price, 29% Discount, Uses, and Side Effects

Name: Platify 25mg Tablet
Brand: platify
Price: 1070 INR
Availability: InStock
Rating: 4.57 (7 reviews)

Description

Platify 25mg Tablet contains Eltrombopag Olamine as an active ingredient. It is prescribed by the doctor to treat low platelet counts in specific blood-related conditions such as chronic ITP, hepatitis C-related thrombocytopenia, or severe aplastic anemia.

Take it exactly as prescribed by the doctor. It promotes the proliferation and differentiation of megakaryocytes, leading to increased platelet formation and reduced bleeding risk in these conditions.

It is mainly given in combination with other medicines to treat a particular condition or increase effectiveness. Take it exactly as prescribed by the doctor.

Uses

Chronic idiopathic thrombocytopenia
Severe Aplastic Anemia
Low platelet count due to ITP or HCV infection

Side Effects

Platify 25mg Tablet can cause multiple side effects, most of which are mild to moderate and often temporary. Patients are advised to inform their healthcare provider immediately if symptoms stays for prolonged period of time.

Nausea
Diarrhea
Vomiting
Increased liver enzymes
Muscle pain
Urinary tract infection

How To Use

The usual dose of Platify 25mg is one tablet daily. It should be taken on an empty stomach, at the same time each day for consistent blood levels. Consult your doctor for individual dosage as it may vary person to person based on its stage and overall health.
Tablet is taken orally with the help of water. Avoid breaking, chewing, biting and crushing of tablet to maintain the medication efficacy.

How It Works

Platify 25mg Tablet contains Eltrombopag, Eltrombopag binds to and activates the trans-membrane domain of the TPO receptor (c-Mpl) on megakaryocyte progenitors in the bone marrow, triggering signaling pathways.
This promotes the proliferation and differentiation of megakaryocytes, leading to increased platelet formation and reduced bleeding risk in conditions like chronic ITP, hepatitis C-related thrombocytopenia, or severe aplastic anemia.

Safety Advice

Alcohol

Avoid the consumption of alcohol while taking Platify 25mg Tablet, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.

Pregnancy

Do not take Platify 25mg Tablet without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period

Breast Feeding

Breastfeeding women should discuss the potential risks and benefits of the Platify 25mg with their healthcare provider before starting treatment.

Driving

Platify 25mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.

Kidney

Share your medical history with the doctor before starting the Platify 25mg Tablet . Do not take it without consulting a doctor if you have any kidney related issue

Liver

Share your medical history with the doctor before starting the Platify 25mg Tablet. Do not take it without consulting a doctor if you have any liver related issue.

FAQs

Platify 25mg Tablet is used to treat low platelet counts in specific blood-related conditions.

References

Wang, K., Xu, P., Lu, S., & Yao, B. (2024). Postmarketing safety of eltrombopag olamine: an analysis of the FDA Adverse Event Reporting System (FAERS). https://pubmed.ncbi.nlm.nih.gov/37087633/
Kabir, S. R., Asaduzzaman, M., Shahinuzzaman, A. D. A., & Alam, M. T. (2025). Eltrombopag olamine induces apoptosis in human breast adenocarcinoma and hepatocellular carcinoma cells through modulation of multiple apoptotic pathways. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/41310342/
Ganorkar, S. B., Bobade, P. S., Prabhu, R. C., Lokwani, D. K., Shinde, R. N., Telange, D. R., ... & Vander Heyden, Y. (2024). Extension of impurity profiling on eltrombopag olamine to in-silico predictions: An effort to exploit correlated forced degradation products and known drug-related substances in drug discovery. Journal of Chromatography B, 1248, 124367. https://pubmed.ncbi.nlm.nih.gov/39547062/
Dandabattina, R., Subramanian, V. B., Merugu, K. S., SharathBabu, H., Katari, N. K., & Kowtharapu, L. P. (2023). Stability-indicating RP-HPLC method development and validation for eltrombopag olamine in the presence of impurities and degradation products. Robustness by design of expert software. Journal of AOAC International, 106(2), 267-275.
Afrin, S., Hasan, S., Mahedi, R. A., Kuri, O. C., Iqbal, H., Kadham, M. J., ... & Rabbi, F. (2024). Eltrombopag olamine in dengue fever: Systematic review of clinical trials and beyond. Research Journal of Pharmacy and Technology, 17(6), 2778-2782.

Platify 25mg Tablet

About The Product